Transcriptoma analyses in triple-negative breast cancer with BRCA1 germline mutation

被引：0
|
作者：
Nakamura, Kivvi Duarte
Ferreira, Elisa
Ramalho, Rodrigo
Brianese, Rafael
Carraro, Dirce
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-1453
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1453
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Prevalence of BRCA1 mutations in women with triple-negative breast cancer: A systematic review
    Tun, N. M.
    Villani, G. M.
    Ong, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [42] The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    Young, S. R.
    Pilarski, Robert T.
    Donenberg, Talia
    Shapiro, Charles
    Hammond, Lyn S.
    Miller, Judith
    Brooks, Karen A.
    Cohen, Stephanie
    Tenenholz, Beverly
    DeSai, Damini
    Zandvakili, Inuk
    Royer, Robert
    Li, Song
    Narod, Steven A.
    BMC CANCER, 2009, 9
  • [43] Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer
    Seth Rummel
    Erika Varner
    Craig D. Shriver
    Rachel E. Ellsworth
    Breast Cancer Research and Treatment, 2013, 137 : 119 - 125
  • [44] Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development
    Oleksii Nikolaienko
    Hans P. Eikesdal
    Elisabet Ognedal
    Bjørnar Gilje
    Steinar Lundgren
    Egil S. Blix
    Helge Espelid
    Jürgen Geisler
    Stephanie Geisler
    Emiel A. M. Janssen
    Synnøve Yndestad
    Laura Minsaas
    Beryl Leirvaag
    Reidun Lillestøl
    Stian Knappskog
    Per E. Lønning
    Genome Medicine, 15
  • [45] Influence of Germline BRCA Genotype on the Survival of Patients with Triple-Negative Breast Cancer
    Villarreal-Garza, Cynthia
    Ferrigno, Ana S.
    Aranda-Gutierrez, Alejandro
    Frankel, Paul H.
    Ruel, Nora H.
    Fonseca, Alan
    Narod, Steven
    Chavarri-Guerra, Yanin
    Sifuentes, Erika
    Magallanes-Hoyos, Maria Cristina
    Herzog, Josef
    Castillo, Danielle
    Alvarez-Gomez, Rosa M.
    Mohar-Betancourt, Alejandro
    Weitzel, Jeffrey N.
    CANCER RESEARCH COMMUNICATIONS, 2021, 1 (03): : 140 - 147
  • [46] Neoadjuvant talazoparib in patients with germline BRCA1/2 mutation-positive, early-stage triple-negative breast cancer: exploration of tumor BRCA mutational status
    Telli, Melinda L.
    Litton, Jennifer K.
    Beck, J. Thaddeus
    Jones, Jason M.
    Andersen, Jay
    Mina, Lida A.
    Brig, Raymond
    Danso, Michael
    Yuan, Yuan
    Symmans, William F.
    Hopkins, Julia F.
    Albacker, Lee A.
    Abbattista, Antonello
    Noonan, Kay
    Mata, Marielena
    Laird, A. Douglas
    Blum, Joanne L.
    BREAST CANCER, 2024, 31 (05) : 886 - 897
  • [47] Triple-negative breast cancer with or without BRCA mutation: looking at the future
    Ballatore, Z.
    Bracci, R.
    Bianchi, F.
    Pistelli, M.
    Maccaroni, E.
    Belvederesi, L.
    Brugiati, C.
    Pagliaretta, S.
    Pagliacci, A.
    Battelli, N.
    Berardi, R.
    BREAST, 2016, 29 : S21 - S21
  • [48] BRCA1 mutation is strongly associated with a triple negative phenotype in breast cancer patients
    Cordoba, O.
    Rubio, I.
    Xercavins, J.
    Diez, O.
    Alvarez, M.
    Cortadellas, T.
    Balmana, J.
    EJC SUPPLEMENTS, 2010, 8 (03): : 108 - 108
  • [49] Clinical Outcome of Triple Negative Breast Cancer in BRCA1 Mutation Carriers and Noncarriers
    Lee, Larissa J.
    Alexander, Brian
    Schnitt, Stuart J.
    Comander, Amy
    Gallagher, Bridget
    Garber, Judy E.
    Tung, Nadine
    CANCER, 2011, 117 (14) : 3093 - 3100
  • [50] Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer
    Arisa Morizono
    Masahiko Tanabe
    Masako Ikemura
    Takeshi Sasaki
    Tetsuo Ushiku
    Yasuyuki Seto
    Journal of Human Genetics, 2021, 66 : 785 - 793
12345